Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-02-18 Sale |
2025-02-20 5:12 pm |
Neumora Therapeutics Inc. | NMRA | Lenz Robert A. Head of R&D |
5,614 | $1.6714 | $9,383 | 309,092 (Direct) |
View |
| 2024-10-09 Sale |
2024-10-11 4:10 pm |
Neumora Therapeutics Inc. | NMRA | Lenz Robert A. Head of R&D |
13,823 | $15.06 | $208,110 | 314,706 (Direct) |
View |
| 2024-09-17 Sale |
2024-09-19 4:35 pm |
Neumora Therapeutics Inc. | NMRA | Lenz Robert A. Head of R&D |
41,464 | $11.89 | $492,827 | 328,529 (Direct) |
View |
| 2024-09-12 Sale |
2024-09-16 4:05 pm |
Neumora Therapeutics Inc. | NMRA | Lenz Robert A. Head of R&D |
32,948 | $11.43 | $376,665 | 369,993 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-13 Option Award |
2025-02-18 4:30 pm |
N/A 2033-09-14 |
Neumora Therapeutics Inc. | NMRA | Lenz Robert A. Head of R&D |
602,934 | $0 | 602,934 (Direct) |
View |
| 2024-02-14 Option Award |
2024-02-16 4:13 pm |
N/A 2034-02-13 |
Neumora Therapeutics Inc. | NMRA | Lenz Robert A. Head of R&D |
150,000 | $0 | 502,941 (Direct) |
View |
| 2023-09-14 Option Award |
2023-09-18 5:58 pm |
N/A 2033-09-13 |
Neumora Therapeutics Inc. | NMRA | Lenz Robert A. Head of R&D |
855,875 | $0 | 855,875 (Direct) |
View |